Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Sarda Proteins
Join Channel
Consolidated Standalone

Sarda Proteins

₹69.6 3.3 | 5%

Market Cap ₹12 Cr.

Stock P/E 600.5

P/B 7.5

Current Price ₹69.6

Book Value ₹ 9.2

Face Value 10

52W High ₹78.5

Dividend Yield 0%

52W Low ₹ 37.7

Edit Ratio

Sarda Proteins Research see more...

Overview Inc. Year: 1991Industry: Edible Oil

Sarda Proteins Ltd engages within the wholesale buying and selling of edible oils and agriculture commodities in India. The corporation trades in mustard oil, subtle oil, and mustard and guar seeds. It also trades in agricultural commodities, along with oil seeds, grains, fit for human consumption oils, etc. The company was founded in 1991 and is based in Jaipur, India.

Read More..

Sarda Proteins Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Sarda Proteins Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 3 7 0 3 2 1 0 0 1 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 3 7 0 3 2 1 0 0 1 0
Total Expenditure 3 6 0 3 2 1 0 0 1 0
Operating Profit 0 0 0 0 0 0 -0 -0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 -0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0 -0 -0 0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 -0
Profit After Tax 0 0 0 0 0 -0 -0 -0 0 0
Adjustments 0 -0 -0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 -0 -0 -0 0 0
Adjusted Earnings Per Share 0.3 1.5 0 0 0 -0.2 -0 -0 0 0.1

Sarda Proteins Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 13 2 5 2 6 6 7 5 11 11 6 1
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 13 2 5 2 6 6 7 5 11 11 6 1
Total Expenditure 13 3 5 2 6 6 7 5 11 10 6 1
Operating Profit -0 -0 -0 -0 -0 -0 -0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 1 0 0 0 0 0 0 -0 0 0
Profit Before Tax -0 -0 1 -0 -0 -0 -0 0 0 0 0 0
Provision for Tax -0 -0 0 -0 -0 -0 0 0 0 0 0 0
Profit After Tax -0 -0 1 -0 -0 -0 -0 0 -0 0 -0 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 -0 1 -0 -0 -0 -0 0 -0 0 -0 0
Adjusted Earnings Per Share -1.3 -0.5 2.4 -0.9 -0.8 -1.9 -0.7 0.2 -0.1 1.8 -0.2 0.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -45% 6% 0% -7%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 36% 36% 47% NA%
ROE Average -2% 6% 2% -2%
ROCE Average 1% 6% 5% -0%

Sarda Proteins Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 2 2 3 3 3 2 2 2 2 2 2
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Total Current Liabilities 0 0 0 1 0 0 0 0 0 0 0
Total Liabilities 2 2 3 3 3 2 2 2 2 2 2
Fixed Assets 0 1 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 1 1 0 1 0 0 0 0 0 0 0
Total Current Assets 1 1 2 2 2 2 2 2 2 2 2
Total Assets 2 2 3 3 3 2 2 2 2 2 2

Sarda Proteins Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 1 1 0 1 0 0 0 0
Cash Flow from Operating Activities -0 -0 -1 -1 -0 0 -1 -0 -0 0 -0
Cash Flow from Investing Activities 0 -0 2 0 -0 0 0 0 0 0 0
Cash Flow from Financing Activities -0 0 -0 0 -0 -0 0 -0 -0 -0 0
Net Cash Inflow / Outflow -0 0 1 -1 -1 0 -0 0 0 0 -0
Closing Cash & Cash Equivalent 0 0 1 1 0 1 0 0 0 0 0

Sarda Proteins Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -1.34 -0.5 2.43 -0.89 -0.77 -1.92 -0.72 0.19 -0.12 1.78 -0.19
CEPS(Rs) -1.13 -0.36 2.6 -0.79 -0.68 -1.85 -0.66 0.21 -0.11 1.78 -0.19
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 9.31 8.81 11.24 10.86 10.09 8.18 7.46 7.65 7.53 9.32 9.13
Core EBITDA Margin(%) -4.57 -5.25 -2.52 -6 -2.66 -6.27 -1.44 1.81 -0.18 2.51 -2.53
EBIT Margin(%) -3.51 -6.51 12.59 -6.78 -2.88 -6.46 -1.16 3.24 0.55 3.28 0.22
Pre Tax Margin(%) -3.56 -7 12.27 -8.14 -3.1 -6.51 -1.21 3.16 0.54 3.28 0.22
PAT Margin (%) -2.6 -4.93 11.78 -7.45 -2.14 -5.85 -1.71 0.61 -0.18 2.86 -0.57
Cash Profit Margin (%) -2.19 -3.59 12.62 -6.59 -1.9 -5.66 -1.59 0.67 -0.17 2.86 -0.57
ROA(%) -9.43 -5.11 23.13 -5.2 -4.7 -15.07 -6.74 1.81 -1.08 14.72 -1.45
ROE(%) -13.46 -5.51 24.23 -6.67 -7.31 -20.98 -9.15 2.52 -1.55 21.15 -2.08
ROCE(%) -17.79 -6.71 23.35 -4.5 -5.96 -14.89 -3.92 8.38 3 15.81 0.55
Receivable days 18.47 16.61 9.24 0 39.17 43.75 35.7 52.53 25.78 16.59 0
Inventory Days 21.63 82.05 37.03 178.8 77.88 47.65 0 0 0 0 0
Payable days 28.6 14.66 1.19 1.01 0.23 0.23 0.03 0 0 0 0
PER(x) 0 0 0 0 0 0 0 0 0 20.94 0
Price/Book(x) 0 0 0 0 0 0.58 0 0 1.39 4 6.33
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.18 1.11 0.31 1.01 0.27 0.05 0.23 0.3 0.15 0.57 1.69
EV/Core EBITDA(x) -5.86 -21.39 -14 -17.14 -10.3 -0.78 -22.32 9.11 26.45 17.17 755.15
Net Sales Growth(%) -53.5 -80.4 103.6 -58.93 199.69 -8.54 27.7 -25.17 110.35 -5.28 -46.14
EBIT Growth(%) -310.95 63.62 494 -122.11 -27.53 -104.97 77.14 309.49 -64.15 463 -96.33
PAT Growth(%) -516.05 62.88 586.88 -125.98 14.04 -150.46 62.68 126.66 -161.6 1616.4 -110.74
EPS Growth(%) -516.06 62.88 586.84 -136.65 14.04 -150.46 62.68 126.66 -161.62 1616.34 -110.74
Debt/Equity(x) 0.02 0.15 0.08 0.23 0.08 0 0 0 0 0 0
Current Ratio(x) 4.14 1.98 7.17 3.28 7.41 42.59 60.82 43.87 57.33 62.92 98.07
Quick Ratio(x) 2.23 0.4 5.83 1.12 4.16 32.19 60.82 43.87 57.33 62.92 98.07
Interest Cover(x) -68.9 -13.11 39.79 -4.98 -13.48 -127.32 -21.46 39.27 43.31 1774.16 498.35
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Sarda Proteins Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 28.41 28.41 28.41 28.41 28.41 28.41 28.41 28.41 28.41 28.41
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 71.59 71.59 71.59 71.59 71.59 71.59 71.59 71.59 71.59 71.59
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 28.41%.
  • Company has a low return on equity of 6% over the last 3 years.
  • Stock is trading at 7.5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sarda Proteins News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!